Best PRN Medication for Non-Controlled Insomnia
Low-dose melatonin (1-3 mg) is the best PRN non-controlled medication for insomnia, taken 1-2 hours before bedtime. 1
First-Line Non-Controlled Options
Melatonin
- Dosage: 1-3 mg for typical insomnia (can be titrated up to 15 mg for specific sleep disorders) 1
- Timing: Take 1-2 hours before bedtime
- Benefits:
- Smaller but consistent effects on sleep latency 1
- Lower risk of daytime sedation 1
- No dependence, tolerance, rebound insomnia or withdrawal symptoms 2
- Mimics natural secretion pattern of melatonin 2
- Particularly effective in adults ≥55 years 2
- No impairment of psychomotor functions, memory recall or driving skills 2
Low-dose Doxepin
- Dosage: 3-6 mg 1
- Best for: Sleep maintenance insomnia 1
- Benefits: Particularly effective in elderly patients 1
Second-Line Non-Controlled Options
Ramelteon
Special Considerations
Elderly Patients (≥65 years)
- Preferred options:
- Caution: Use lower doses of all medications due to increased sensitivity and fall risk 1
Patients with Respiratory Conditions
- Use lower doses of medications due to increased sensitivity and risk of respiratory depression 1
- Consider ramelteon as it has minimal respiratory effects 1
Patients with History of Substance Use
- Prefer non-scheduled options like ramelteon or doxepin 1
Monitoring and Follow-up
- Assess sleep parameters within 2-4 weeks of starting treatment 1
- Monitor for side effects, particularly daytime sedation, falls, and cognitive changes 1
Important Caveats
- Avoid sedating antihistamines (like diphenhydramine) despite their OTC availability, as they have anticholinergic effects and are particularly problematic in older adults 4, 5
- Avoid combining medications with sedating effects due to risk of excessive sedation and respiratory depression 1
- Remember that non-pharmacologic interventions, particularly Cognitive Behavioral Therapy for Insomnia (CBT-I), should be considered first-line treatment for chronic insomnia 1
- If insomnia persists despite appropriate medication trials, consider referral to a sleep specialist 1